1. Home
  2. KURA vs DNN Comparison

KURA vs DNN Comparison

Compare KURA & DNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KURA
  • DNN
  • Stock Information
  • Founded
  • KURA 2014
  • DNN 1936
  • Country
  • KURA United States
  • DNN Canada
  • Employees
  • KURA N/A
  • DNN N/A
  • Industry
  • KURA Biotechnology: Biological Products (No Diagnostic Substances)
  • DNN Other Metals and Minerals
  • Sector
  • KURA Health Care
  • DNN Basic Materials
  • Exchange
  • KURA Nasdaq
  • DNN Nasdaq
  • Market Cap
  • KURA 793.2M
  • DNN 1.8B
  • IPO Year
  • KURA N/A
  • DNN 1997
  • Fundamental
  • Price
  • KURA $7.26
  • DNN $1.91
  • Analyst Decision
  • KURA Strong Buy
  • DNN Strong Buy
  • Analyst Count
  • KURA 11
  • DNN 2
  • Target Price
  • KURA $27.89
  • DNN $3.00
  • AVG Volume (30 Days)
  • KURA 1.8M
  • DNN 22.9M
  • Earning Date
  • KURA 02-25-2025
  • DNN 02-27-2025
  • Dividend Yield
  • KURA N/A
  • DNN N/A
  • EPS Growth
  • KURA N/A
  • DNN N/A
  • EPS
  • KURA N/A
  • DNN N/A
  • Revenue
  • KURA N/A
  • DNN $2,920,167.00
  • Revenue This Year
  • KURA N/A
  • DNN $226.79
  • Revenue Next Year
  • KURA $233.30
  • DNN $133.88
  • P/E Ratio
  • KURA N/A
  • DNN N/A
  • Revenue Growth
  • KURA N/A
  • DNN N/A
  • 52 Week Low
  • KURA $6.98
  • DNN $1.40
  • 52 Week High
  • KURA $24.17
  • DNN $2.47
  • Technical
  • Relative Strength Index (RSI)
  • KURA 17.38
  • DNN 42.37
  • Support Level
  • KURA $6.98
  • DNN $1.89
  • Resistance Level
  • KURA $8.88
  • DNN $2.01
  • Average True Range (ATR)
  • KURA 0.33
  • DNN 0.10
  • MACD
  • KURA 0.05
  • DNN 0.00
  • Stochastic Oscillator
  • KURA 13.40
  • DNN 30.02

About KURA Kura Oncology Inc.

Kura Oncology Inc is a clinical-stage biopharmaceutical company, that engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers. It focuses on the development of small-molecule product candidates that target cell signaling pathways to drive the progression of various cancers. The company has a product candidate, Tipifarnib, which is a farnesyl transferase inhibitor, in both solid tumors and blood cancers. Geographically operation of the group is carried through the United States.

About DNN Denison Mines Corp (Canada)

Denison Mines Corp is a uranium exploration and development company with interests focused in the Athabasca Basin region of northern Saskatchewan, Canada. The company has an effective 95% interest in its flagship Wheeler River Uranium Project, which is the largest undeveloped uranium project in the infrastructure-rich eastern portion of the Athabasca Basin region of northern Saskatchewan. The company is also engaged in mine decommissioning and environmental services through its Closed Mines group, which manages its Elliot Lake reclamation projects and provides third-party post-closure mine care and maintenance services.

Share on Social Networks: